JACC Author Interviews podcast

Behind the Science: Can IL-6 Improve Cardiovascular Risk Assessment? Findings From the CCC Study | JACC Author Interviews

0:00
20:07
Reculer de 15 secondes
Avancer de 15 secondes

In this episode of Behind the Science, we sit down with Dr Yao to discuss the recent JACC publication, "The Prognostic Value of Serum Interleukin-6 Concentrations for 9 Cardiovascular and Mortality Outcomes: The Cross Cohort Collaboration (CCC)." The discussion explores the growing role of interleukin-6 (IL-6) as a key inflammatory biomarker in cardiovascular disease and its potential value beyond traditional markers such as high-sensitivity C-reactive protein (hsCRP). Drawing on data from more than 320,000 participants across multiple community-based cohorts, the study examined associations between IL-6 and nine major cardiovascular and mortality outcomes, including myocardial infarction, stroke, atrial fibrillation, heart failure, cardiovascular mortality, and all-cause mortality. #JACC #Cardiology #IL6 #Inflammation #CardiovascularDisease #HeartFailure #Prevention #Biomarkers #ClinicalResearch #BehindTheScience

D'autres épisodes de "JACC Author Interviews"